Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novadaq buys fluoro endoscopy technology:

This article was originally published in Clinica

Executive Summary

Toronto-based developer of real-time medical imaging systems Novadaq Technologies is to acquire certain business assets, including a portfolio of fluorescence endoscopy patents, from fellow Canadian medical device company Xillix Technologies. Under the terms of the agreement, Novadaq will pay Xillix Can$3m ($2.7m) on closing, in exchange for the latter's auto-fluorescence and multi-modal imaging portfolio of 31 issued patents and multiple pending patents in the US, Japan and Europe. The purchase also includes the rights to Xillix's pipeline fluorescence imaging technologies. The transaction is slated to close in early May.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048217

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel